IQVIA.ai Launch With NVIDIA Puts IQVIA's AI Valuation In Focus [Yahoo! Finance]
IQVIA Holdings, Inc. (IQV)
Last iqvia holdings, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.iqvia.com
Company Research
Source: Yahoo! Finance
IQVIA Holdings (NYSE:IQV) has launched IQVIA.ai, a proprietary AI platform built in partnership with NVIDIA. The platform is designed to support new applications across life sciences operations, from research to commercial activities. IQVIA, a major player in clinical research and healthcare data services, is moving deeper into AI with IQVIA.ai, aiming to apply advanced computing to the complex demands of life sciences. For readers tracking NYSE:IQV, this development sits at the intersection of data, software and AI, an area that has drawn growing interest across pharma, biotech and healthcare technology. The NVIDIA partnership points to a focus on high performance infrastructure for handling large scale healthcare and clinical datasets. For investors, IQVIA.ai may influence how NYSE:IQV competes for contracts, shapes new product offerings and responds to client demand for AI enabled tools. The extent of commercial impact will depend on how quickly life sciences customers adopt
Show less
Read more
Impact Snapshot
Event Time:
IQV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IQV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IQV alerts
High impacting IQVIA Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
IQV
News
- Lilly weight loss pill prescriptions said to near 1,400 in first week of launch [Seeking Alpha]Seeking Alpha
- IQVIA to Announce First-Quarter 2026 Results on May 5, 2026Business Wire
- MEDDDICAL Launches Real-World Evidence Strategy & Analytics For Pharma & MedTech [TheStreet.com]TheStreet.com
- IQVIA (IQV) had its "outperform" rating reaffirmed by Evercore Inc.MarketBeat
- UPSHER-SMITH LAUNCHES GENERIC VERSION OF CIPRODEX® (CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1%) STERILE OTIC SUSPENSION [TheStreet.com]TheStreet.com
IQV
Earnings
- 2/5/26 - Beat
IQV
Sec Filings
- 3/27/26 - Form SCHEDULE
- 2/27/26 - Form ARS
- 2/27/26 - Form DEFA14A
- IQV's page on the SEC website